Dawn Landolph, RN, BSN, OCN, MPA, provides an in-depth look at adagrasib for the treatment of patients with KRAS G12C-mutated, locally advanced or metastatic non-small cell lung cancer in a downloadable reference sheet.
Rx Road Map: Adagrasib (Krazati)
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Subcutaneous Daratumumab in High-Risk Smoldering Myeloma
2
Frontline Vaccine/Pembro Yields PFS Benefit in Advanced Melanoma
3
APP-Led Quality Assurance Group Is Feasible, Identifies Safety Events
4
What an Oncology APP Should Know About Exercise in Cancer Care
5
